<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-01T09:44:09Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/14280" metadataPrefix="qdc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/14280</identifier><datestamp>2026-02-03T11:51:17Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><qdc:qualifieddc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Total synthesis of depudecin and analogues via an olefin cross-metathesis based strategy</dc:title>
   <dc:creator>Cheng-Sánchez, Iván</dc:creator>
   <dc:creator>Sarabia-García, Francisco Ramón</dc:creator>
   <dc:subject>Antineoplásicos</dc:subject>
   <dcterms:abstract>(-)-Depudecin (1), isolated from the culture broths of the fungus Alternaria brassicicola [1], has been identified as a selective inhibitor of histone deacetylases (HDAC) with an IC50 in the low μM range. In contrast to representative HDAC inhibitors, depudecin represents a unique inhibitor of these enzymes by virtue of its molecular structure, featuring the presence of two oxirane rings separated by a trans double bond. Originally discovered as part of a biological screen directed towards the identification of antitumour agents with detransforming activity [2], depudecin was identified as a bioactive metabolite capable of reverting the transformed morphology of tumor cells. Depudecin induced cell cycle arrest and cellular differentiation [3], and also exhibited anti-angiogenesis activity [4]. Prompted by its striking biological properties and enticing structure, we decided to initiate a research program directed towards the synthesis of natural depudecin which has recently culminated with a linear total synthesis [5]. In order to develop an improved access to natural depudecin and analogues for further biological screenings, we explored a synthetic alternative as a shorter and more convergent approach. In this communication we report a new total synthesis of the natural product (-)-depudecin. A key feature of the synthesis is the utilization of an olefin cross-metathesis strategy, which provides for an efficient and improved access to natural depudecin. This strategy was applied to the preparation of the 10-epi and (+)-depudecin, which represent interesting stereoisomeric analogues for SAR studies.</dcterms:abstract>
   <dcterms:dateAccepted>2017-07-20T09:44:46Z</dcterms:dateAccepted>
   <dcterms:available>2017-07-20T09:44:46Z</dcterms:available>
   <dcterms:created>2017-07-20T09:44:46Z</dcterms:created>
   <dcterms:issued>2017-07-20</dcterms:issued>
   <dc:type>conference output</dc:type>
   <dc:identifier>http://hdl.handle.net/10630/14280</dc:identifier>
   <dc:identifier>http://orcid.org/X0000-0002-5149-3576</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>20th European Symposium on Organic Chemistry (ESOC 17)</dc:relation>
   <dc:relation>Colonia, Alemania</dc:relation>
   <dc:relation>Julio, 2017</dc:relation>
   <dc:rights>open access</dc:rights>
   <dc:rights>by-nc-nd</dc:rights>
</qdc:qualifieddc>
</metadata></record></GetRecord></OAI-PMH>